Thymulin vs Thymalin: what's the difference?

Reviewed 14 sourcesPublished by PepVault

Thymulin is one zinc-bound thymus hormone; Thymalin is a Russian calf-thymus extract. What each one is, what the studies found, and how to keep them apart.

A woman in white linen doing tai chi on a misty lawn
Last reviewed
Sources
14
Questions
10
Compounds
3

The short answer

Thymulin and Thymalin are two different things that both come from the thymus. Thymulin is a single hormone: nine amino acids that the thymus releases into the blood and that works only with zinc bound to it. Thymalin is a Russian drug: an extract of calf thymus holding many peptides. A study of one tells you nothing about the other.

Every number checked at its primary source · · 14 sources · How we research

Evidence: Early for both: thymulin has three 1980s randomized trials with mixed results (two in arthritis, one in multiple sclerosis) plus strong recent mouse and cell work; Thymalin has its developers' human studies, not described as randomized.

A woman in white linen doing tai chi on a misty lawn

What is thymulin?

Thymulin is a hormone your own body makes. The thymus, the small gland behind the breastbone where T cells (the immune cells that recognise infected and abnormal cells) learn their job, releases it into the blood. The Paris immunologist Jean-François Bach and his team found it in the 1970s and first called it FTS, for facteur thymique sérique, the "serum thymic factor"1. It was first isolated from pig serum2.

Its structure is short and exact: nine amino acids in a fixed order, pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn2. The odd part is the metal. Thymulin only works with one zinc atom bound to each molecule, and the zinc gives it its working shape23. Both its activity and the shape antibodies recognise depend on that zinc3. Thymic epithelial cells, the lining cells of the thymus, make it23.

Its job, from decades of work in animals and cells, is to help T cells mature, inside the thymus and after they leave it23. In lab studies it also calms inflammatory signals from immune cells, the thread the newest research pulls on613.

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault's bloodwork section records each panel by its test date, zinc and white blood cell count among the markers, and draws each marker's trend, so results before and after a course sit on one line.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What is Thymalin?

Thymalin is a drug, not a hormone. It is a mixture of peptides pulled out of calf thymus with a mild acid, made by Vladimir Morozov and Vladimir Khavinson's group in St. Petersburg and used in Russia to correct a weak immune system4. It was one of the first two products of the bioregulator program that later gave the world Epitalon; the Khavinson bioregulators guide tells that story, and pepvault.app/bioregulators lists the whole family.

Because it is an extract, Thymalin has no single sequence. The active parts its developers name are two dipeptides, peptides only two amino acids long: Lys-Glu (KE) and Glu-Trp (EW)5. The group isolated Glu-Trp from Thymalin and made it into a drug of its own, Thymogen4. Thymulin turned up in calf thymus extract in early work2, but it is not among the active parts Thymalin's developers name.

How do thymulin and Thymalin compare side by side?

At a glanceThymulinThymalin
What it isOne natural hormone of the thymus3A drug: a peptide extract of calf thymus4
StructureNine amino acids plus one zinc atom2A mixture; named active parts are the dipeptides KE and EW5
Where it comes fromYour own thymus; also made synthetically3Calf thymus, by acid extraction4
Who studied itBach and Dardenne in Paris, then groups in Italy and the US61011Almost entirely its developers in St. Petersburg4512
Best human evidenceTwo randomized, placebo-controlled trials in rheumatoid arthritis7A 266-person follow-up of older adults, not described as randomized12
Newest headlineLowered age-related inflammation and slowed tumors in old mice, 20266Added to standard care in severe COVID-19, in the developers' reports5
Measured in blood?Yes, as a marker of thymus output and zinc status911No; it is given, not measured
Thymulin as nine beads held in shape by one zinc atom, beside Thymalin as a jar of many short fragments with two, KE and EW, highlighted
Thymulin is one defined peptide that needs zinc; Thymalin is a mixture from calf thymus whose named active parts are two dipeptides.

The one link between them is the organ. Both trace back to the thymus, and both were studied as ways to support an immune system that weakens with age. Past that, they differ as insulin differs from a pancreas extract.

What did the 2026 thymulin study find?

The most striking thymulin result is the newest. In July 2026 a surgery and immunology team at the University of Southern California published a study in Nature Communications asking why inflammation climbs with age and helps tumors grow6. Old mice and older people both had more of the myeloid cells, the first-responder immune cells, that pour out the inflammatory signals IL-1α, IL-1β, IL-6 and TNF-α.

When the team joined the blood supply of old and young mice, the young blood calmed the old animals' myeloid cells. Hunting for the factor, they landed on thymulin, a thymus product that falls with age, and showed it turns down NF-κB, the master switch inside the cell that turns on those inflammatory genes6.

  • In human cells: in blood cells from 14 older donors (52 to 86), 24 hours of thymulin in a dish cut the share of myeloid cells making IL-1α, IL-1β, IL-6 and TNF-α; the authors call the effect age-dependent, set against cells from 14 young donors (21 to 28)6.
  • In old mice: a week of daily thymulin cut the share of inflammatory myeloid cells in the blood; in young mice it had no significant effect6.
  • In old mice with breast tumors: thymulin slowed tumor growth and lengthened survival, and it made tumors respond to an anti-PD-L1 drug, a common cancer immunotherapy, that did nothing on its own in old mice6.

The pattern matters: thymulin did little in young animals and a lot in old ones, so the authors read it as restoring something lost with age rather than boosting immunity across the board6. An older line of work points the same way: in animals, thymulin given before an inflammatory challenge eased the pain it caused and, in early results, blocked NF-κB in the brain13.

The tumor and survival results are in mice, and the human part was in blood cells in a dish. No one has yet given thymulin to older people to test any of this.

Has thymulin been tested in people?

Yes, in the 1980s, as a synthetic version called nonathymulin. At Cochin Hospital in Paris, Bach's colleagues ran two randomized, double-blind, placebo-controlled trials in rheumatoid arthritis, an autoimmune disease of the joints, comparing 1, 5 and 10 mg a day7. The 5 mg dose did best: 56% of patients improved on the global assessment against 17% on placebo, with four objective measures also better and minimal side effects7.

A second test did not go the same way. In a randomized, double-blind trial of 40 people with multiple sclerosis, six months of nonathymulin under the skin did no better than placebo on disability scores, with no significant side effects8. PubMed indexes no larger trial after these, and Drugs@FDA lists no approval for thymulin.

The trial doses above are those trials' doses, told as what was tested, not as an amount for anyone to use.

Why do zinc studies measure thymulin?

Because thymulin needs zinc to work, its activity in blood drops when the body runs low on zinc, even before standard zinc levels show anything. In a 1988 study in Detroit, people with mild zinc deficiency, whose plasma zinc still read normal, had lower thymulin activity, and zinc brought it back, both in the body and in the test tube9. The authors called it a sensitive sign of mild zinc deficiency.

A small randomized trial showed the same in Crohn's disease. Twenty-seven patients in remission took 60 mg of zinc sulphate a day, 200 mg or a placebo for three months; plasma zinc and thymulin rose significantly only on the 200 mg dose10.

A schematic curve of blood thymulin with age: present at birth, peaking between 5 and 10, falling through adolescence, and flat at its lowest from 36 to 80
Thymulin peaks in childhood and settles at its lowest by the mid-thirties (93 healthy people, Consolini 2000).

Thymulin also tracks age. In 93 healthy people from birth to 80, thymulin was present at birth, peaked in children aged 5 to 10, fell from adolescence, and reached its lowest at 36, staying there through 8011. That fall is what the 2026 study built on. The thymulin tests in these studies were research assays; the big US lab chains list none.

PepVault's bloodwork section records each panel by its test date, zinc and white blood cell count among the markers, and draws each marker's trend, so results before and after a course sit on one line. Log it in PepVault

What does the evidence for Thymalin look like?

Thymalin's best-known number comes from its developers' long follow-up of 266 older adults: over six to eight years, deaths were 2.0 to 2.1 times fewer in the group given Thymalin than in the control group12. The study was not described as randomized or blinded, and no outside group has repeated it; its page is pepvault.app/research/thymalin-khavinson-2003. In lab work on human blood cells, Thymalin and its two dipeptides lowered IL-1β, IL-6 and TNF-α by 1.4 to 6.0 times5.

So both peptides land on the same inflammatory signals in human cells, which is part of why the names get blurred. The difference is who checked: thymulin's anti-inflammatory effect now has an independent US lab behind it6, while Thymalin's rests on its developers. The bioregulator guide walks through how to weigh the St. Petersburg studies.

Where do Thymogen and thymosin alpha-1 fit?

Two more names add to the mix-up. Thymogen is Glu-Trp, the dipeptide isolated from Thymalin and made into a drug of its own4; it is a part of Thymalin, not of thymulin. Thymosin alpha-1 is a third molecule: 28 amino acids cut from a larger protein, prothymosin alpha14. It is a separate peptide with its own page in the PepVault library.

What do people who use them report?

Commonly reported: little to feel during a Thymalin course, usually run as about a week to ten days and then not for months, with soreness where it goes in as the usual complaint. Reports on thymulin itself are few.

Since neither tends to produce a felt change, the studies read people through blood work: lymphocyte counts and inflammatory markers for Thymalin, zinc and thymulin activity for thymulin. A dated record of what you took and when is the only way to line a course up against your own results later.

PepVault logs each dose of a course with its date and time and can remind you on each day of it, so the start and end of a run are on record. Set reminders in PepVault

When to get help If you have an autoimmune disease or a cancer, or take a drug that changes how your immune system works, talk to your doctor before a course of either.

How do you tell which one a claim is about?

  1. Look for zinc. A claim about a zinc-bound peptide, zinc deficiency or a nine-amino-acid sequence is about thymulin.
  2. Look for an extract. A claim about calf thymus, Khavinson, St. Petersburg, "bioregulators" or the 266-person study is about Thymalin.
  3. Check the species. Thymulin's newest results are in mice and in human cells in a dish; its human trials are from the 1980s.
  4. Check who ran it. Thymalin's human studies come from its developers; thymulin's come from several independent groups.
  5. Do not move a result across. A Thymalin mortality figure says nothing about thymulin, and the 2026 mouse study says nothing about Thymalin.

Track it in the app

Sources

  1. Bach JF, Dardenne M, Pleau JM, Rosa J. Biochemical characterisation of a serum thymic factor. Nature. 1977. PubMed 300146
  2. Dardenne M, Pleau JM. Interactions between zinc and thymulin. Met Based Drugs. 1994. PubMed 18476235
  3. Bach JF, Dardenne M. Thymulin, a zinc-dependent hormone. Med Oncol Tumor Pharmacother. 1989. PubMed 2657247
  4. Morozov VG, Khavinson VK. Natural and synthetic thymic peptides as therapeutics for immune dysfunction. Int J Immunopharmacol. 1997. PubMed 9637345
  5. Linkova N, et al. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. Int J Mol Sci. 2023. PubMed 37686182
  6. Kanemaru H, Luong S, Yamamoto Y, Mizukami Y, Ito F. Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy. Nat Commun. 2026. PubMed 42481458
  7. Amor B, Dougados M, Mery C, Dardenne M, Bach JF. Nonathymulin in rheumatoid arthritis: two double blind, placebo controlled trials. Ann Rheum Dis. 1987. PubMed 3310925
  8. Roullet E, et al. Nonathymulin treatment of multiple sclerosis: double-blind pilot study. Acta Neurol Scand. 1989. PubMed 2618585
  9. Prasad AS, et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988. PubMed 3262625
  10. Brignola C, et al. Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn's disease. Aliment Pharmacol Ther. 1993. PubMed 8364132
  11. Consolini R, Legitimo A, Calleri A, Milani M. Distribution of age-related thymulin titres in normal subjects through the course of life. Clin Exp Immunol. 2000. PubMed 10971509
  12. Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003. PubMed 14523363
  13. Dardenne M, Saade N, Safieh-Garabedian B. Role of thymulin or its analogue as a new analgesic molecule. Ann N Y Acad Sci. 2006. PubMed 17192563
  14. UniProt. P06454, Prothymosin alpha (human): the thymosin alpha-1 peptide, residues 2 to 29. uniprot.org

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo